| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/27/2001 | US6194210 Hepatitis A virus culture process |
| 02/27/2001 | US6194208 Modified milk growth factor |
| 02/27/2001 | US6194207 Methods for the selective expansion of lymphocytes by in vitro cultivation |
| 02/27/2001 | US6194206 Use of oligonucleotide telomerase inhibitors to reduce telomere length |
| 02/27/2001 | US6194205 Multistep process using conditionally immortalized antigen-presenting cells which are engineered to express antigen of interest, adding leukocytic cells, and culturing mixture to activate the t cells |
| 02/27/2001 | US6194204 Enrichment of dendritic cells from blood |
| 02/27/2001 | US6194203 Capable of undergoing at least 60 passages in culture due to expression of viral gene; expresses metabolic markers and metabolic differentiation markers for non-immortalized cells; drug, metabolic, and toxicity screening of intestinal cells |
| 02/27/2001 | US6194202 Parthenogenic oocyte activation |
| 02/27/2001 | US6194201 Expression system for anaerobic gene expression in higher plants |
| 02/27/2001 | US6194191 Method for the production and purification of adenoviral vectors |
| 02/27/2001 | US6194187 Apoptosis-inducing protein and gene encoding the same |
| 02/27/2001 | US6194186 Human protein kinase and kinase inhibitors |
| 02/27/2001 | US6194172 Cytokine designated lerk-6 |
| 02/27/2001 | US6194171 Also vectors, transformed cells; useful for expression in cells for the purposes of identifying agonists or antagonists of ataxin-2-binding protein function |
| 02/27/2001 | US6194162 Method of screening for compounds that bind P2x receptor |
| 02/27/2001 | US6194157 Method for separating biological substances by using photoresist |
| 02/27/2001 | US6194156 Isolated nucleic acid molecules which encode TAGE molecules, and uses thereof |
| 02/27/2001 | US6194153 Methods for determining risk of developing alzheimer's disease by detecting mutations in the presenilin 1 (PS-1) gene |
| 02/27/2001 | US6194152 Nucleotide sequences for the diagnosis and treatment of human urogenital cancers |
| 02/27/2001 | US6194151 Nucleotide sequences coding binding polypeptide; for the detection of modulators of tumor necrosis factor activity; for the treatment of cell proliferation and differentiation defects |
| 02/27/2001 | US6194138 Method for flushing blood cells using gelatin |
| 02/27/2001 | US6193981 Methods and compositions for impairing multiplication of HIV-1 |
| 02/27/2001 | US6193980 Replication defective herpes simplex virus comprising heterologous inserts |
| 02/27/2001 | US6193975 Use of potentilla erecta extract in the cosmetic and pharmaceutical field |
| 02/27/2001 | US6193972 Hybrid heterodimeric protein hormone |
| 02/27/2001 | US6193967 Administering bispecific molecule, comprising: binding specificity for human high density lipoprotein (hdl), or fragment and for an fc.gamma. receptor for immunoglobulin g for treating and prophylaxis of atherosclerosis |
| 02/27/2001 | US6193965 Administering therapeutically effective amount of reagent which modulates kinase activity for treating cell proliferative disorder associated with c-jun n-terminal kinase disorder, |
| 02/27/2001 | US6193963 Method of treating tumor-bearing patients with human plasma hyaluronidase |
| 02/27/2001 | US6193577 Alternative medicine elements package |
| 02/27/2001 | CA2232789C Method for treating alzheimer's disease using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 02/27/2001 | CA2195784C Fumonisin-detoxifying enzymes |
| 02/27/2001 | CA2025598C Chimaeric hepadnavirus core antigen proteins |
| 02/27/2001 | CA1341191C Detection of neu gene expression and products |
| 02/22/2001 | WO2001013117A2 Proteins, genes and their use for diagnosis and treatment of breast cancer |
| 02/22/2001 | WO2001012845A1 Screening for udp-glucose: glycoprotein glucosyltransferase (uggt) activity |
| 02/22/2001 | WO2001012826A2 Nucleic acid molecules derived from plants which code for enzymes which are involved in the synthesis of starch |
| 02/22/2001 | WO2001012825A1 Herbicide-tolerant protoporphyrinogen oxidase |
| 02/22/2001 | WO2001012819A2 Protein phosphatases and diagnosis and treatment of phosphatase-related disorders |
| 02/22/2001 | WO2001012818A1 Neutral cerebral-sphingomyelinase |
| 02/22/2001 | WO2001012815A1 Coxsackie virus-derived vector system for gene transfer |
| 02/22/2001 | WO2001012811A1 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 02/22/2001 | WO2001012807A1 MODIFIED cDNA OF RAT bcl-x GENE AND MODIFIED PROTEIN |
| 02/22/2001 | WO2001012806A2 Odorant-binding human proteins fixing hydrophobic ligands: polypeptides and polynucleotides coding for said polypeptides and uses thereof |
| 02/22/2001 | WO2001012805A1 Methods for diagnosis and treatment of human diseases including hypertension |
| 02/22/2001 | WO2001012800A2 Method for the production of calendic acid, a fatty acid containing delta-8,10,12 conjugated double bonds and dimorphecolic acid, a fatty acid containing a 9-hydroxy group and delta-10,12 conjugated double bonds |
| 02/22/2001 | WO2001012790A2 Isomerase proteins |
| 02/22/2001 | WO2001012786A1 Retinoid receptor interacting polynucleotides, polypeptides, and antibodies |
| 02/22/2001 | WO2001012785A1 Ex vivo generation of functional osteoclasts from bone marrow in a three-dimensional bioreactor |
| 02/22/2001 | WO2001012784A1 METHOD FOR TREATMENT OF β-HEMOGLOBINOPATHIES |
| 02/22/2001 | WO2001012783A2 Motile sperm separation by cellulose derivatives |
| 02/22/2001 | WO2001012782A2 Transgenically modified plant cells and plants having modified gbssi- and be-protein activity |
| 02/22/2001 | WO2001012781A1 13 human colon and colon cancer associated proteins |
| 02/22/2001 | WO2001012777A2 Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species |
| 02/22/2001 | WO2001012776A2 18 human secreted proteins |
| 02/22/2001 | WO2001012775A2 25 human secreted proteins |
| 02/22/2001 | WO2001012674A1 Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof |
| 02/22/2001 | WO2001012673A1 Pgpcr-3 polypeptides and dna sequences thereof |
| 02/22/2001 | WO2001012672A2 Cytokine receptor common gamma chain like |
| 02/22/2001 | WO2001012671A1 Human tumor necrosis factor receptor tr16 |
| 02/22/2001 | WO2001012670A1 Tgf-beta receptor polynucleotides, polypeptides, and antibodies |
| 02/22/2001 | WO2001012665A2 Helical cytokine zalpha48 |
| 02/22/2001 | WO2001012664A2 Notch receptor ligands and uses thereof |
| 02/22/2001 | WO2001012663A2 Hematopoietic regulatory factors and methods of use thereof |
| 02/22/2001 | WO2001012662A2 Membrane associated proteins |
| 02/22/2001 | WO2001012648A1 Novel transcription factor, bp1 |
| 02/22/2001 | WO2001012598A2 METHODS OF INHIBITING BINDING OF β-SHEET FIBRIL TO RAGE AND CONSEQUENCES THEREOF |
| 02/22/2001 | WO2001012207A1 Mechanically elongated neuronal cells and methods for producing and using these cells |
| 02/22/2001 | WO2001012182A1 Use of proteinase inhibitor in order to inhibit the cleavage of growth factor precursor |
| 02/22/2001 | WO2001012172A1 Treatment of metastatic disease |
| 02/22/2001 | WO2001012127A2 TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR |
| 02/22/2001 | WO2000078941A3 Methods and products for manipulating uncoupling protein expression |
| 02/22/2001 | WO2000077179A3 Human poly(adp-ribose) polymerase 2 materials and methods |
| 02/22/2001 | WO2000071737A3 Improved retroviral production by inhibition of the enveloppe cell receptor |
| 02/22/2001 | WO2000071155A3 New vaccine formulations - 2 |
| 02/22/2001 | WO2000069470A3 Improved cellular uptake of bioactive agents |
| 02/22/2001 | WO2000061765A3 Lipoxygenase proteins and polynucleotides encoding the same |
| 02/22/2001 | WO2000061761A3 Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines |
| 02/22/2001 | WO2000049138A3 Pluripotential cells derived from embryonal teratocarcinoma cells and the nucleus of stomatic cells |
| 02/22/2001 | WO2000048642B1 Biocompatible material with a novel functionality |
| 02/22/2001 | WO2000040614A3 Characterization of the soc/crac calcium channel protein family |
| 02/22/2001 | WO2000039297A3 Il-1 related polypeptides |
| 02/22/2001 | WO2000036107A3 Compositions and methods for therapy and diagnosis of ovarian cancer |
| 02/22/2001 | WO2000023100A8 Genes and proteins predictive and therapeutic for renal disease and associated disorders |
| 02/22/2001 | WO2000021549A8 A method of inducing or enhancing chondrogenesis with extracellular matrix containing gdf-5 |
| 02/22/2001 | WO1999047553A3 Bacterial yeal family members as targets for antimicrobial drug design |
| 02/22/2001 | DE19939578A1 New nucleic acid encoding hemocyanin, useful for gene therapy of tumors and for recombinant production of fusion proteins for vaccination |
| 02/22/2001 | DE19939095A1 Von Coxsackieviren abgeleitetes Vektorsystem für Gentransfer Of coxsackie-derived vector system for gene transfer |
| 02/22/2001 | DE19937643A1 Transgene Zellen und Pflanzen mit veränderter Aktivität des GBSSI- und des BE-Proteins Transgenic cells and plants with altered activity of the GBSSI and BE protein |
| 02/22/2001 | DE19937348A1 Nukleinsäuremoleküle aus Pflanzen codierend Enzyme, die an der Stärkesynthese beteiligt sind Nucleic acid molecules encoding enzymes from plants, which are involved in starch synthesis |
| 02/22/2001 | CA2814822A1 Method for the production of calendic acid, a fatty acid containing delta-8,10,12 conjugated double bonds and related fatty acids having a modification at the delta-9 position |
| 02/22/2001 | CA2464845A1 Hematopoietic regulatory factors and methods of use thereof |
| 02/22/2001 | CA2385487A1 13 human colon and colon cancer associated proteins |
| 02/22/2001 | CA2385475A1 18 human secreted proteins |
| 02/22/2001 | CA2385431A1 Tgf-beta receptor polynucleotides, polypeptides, and antibodies |
| 02/22/2001 | CA2383922A1 Cytokine receptor common gamma chain like |
| 02/22/2001 | CA2383691A1 Human tumor necrosis factor receptor tr16 |
| 02/22/2001 | CA2382251A1 Methods for diagnosis and treatment of human diseases including hypertension |
| 02/22/2001 | CA2382239A1 Screening for udp-glucose: glycoprotein glucosyltransferase (uggt) activity |
| 02/22/2001 | CA2382148A1 25 human secreted proteins |
| 02/22/2001 | CA2382095A1 Methods of inhibiting binding of .beta.-sheet fibril to rage and consequences thereof |